Teva Women's Health
Quick facts
Phase 3 pipeline
- DR-103 · Women's Health
DR-103 is a medication used to treat a specific condition by targeting a particular biological pathway.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Teva Women's Health
What is Teva Women's Health's pipeline?
Teva Women's Health has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include DR-103.
Related
- Sector hub: All tracked pharma companies